Pinnacle West Capital (PNW) Forms $80.56 Double Bottom; 1 Analysts Covering AngioDynamics, Inc. (ANGO)

AngioDynamics, Inc. (NASDAQ:ANGO) Logo

Among 3 analysts covering Angiodynamics (NASDAQ:ANGO), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Angiodynamics had 5 analyst reports since January 5, 2018 according to SRatingsIntel. Craig Hallum downgraded AngioDynamics, Inc. (NASDAQ:ANGO) on Friday, January 5 to “Hold” rating. Canaccord Genuity maintained the stock with “Hold” rating in Thursday, January 4 report. The firm has “Outperform” rating by Raymond James given on Tuesday, April 3. On Thursday, March 29 the stock rating was maintained by Canaccord Genuity with “Hold”. The stock of AngioDynamics, Inc. (NASDAQ:ANGO) has “Hold” rating given on Monday, April 2 by Canaccord Genuity. See AngioDynamics, Inc. (NASDAQ:ANGO) latest ratings:

03/04/2018 Broker: Raymond James Old Rating: Market Perform New Rating: Outperform Upgrade
02/04/2018 Broker: Canaccord Genuity Old Rating: Hold New Rating: Hold Old Target: $16.5 New Target: $17 Maintain
29/03/2018 Broker: Canaccord Genuity Rating: Hold New Target: $17.0000 Maintain
04/01/2018 Broker: Canaccord Genuity Rating: Hold New Target: $16.5 Maintain
05/01/2018 Broker: Craig Hallum Rating: Hold Downgrade

Pinnacle West Capital Corporation (PNW) formed double bottom with $77.34 target or 4.00% below today’s $80.56 share price. Pinnacle West Capital Corporation (PNW) has $9.02B valuation. The stock decreased 0.02% or $0.02 during the last trading session, reaching $80.56. About 737,847 shares traded. Pinnacle West Capital Corporation (NYSE:PNW) has declined 10.37% since July 1, 2017 and is downtrending. It has underperformed by 22.94% the S&P500. Some Historical PNW News: 08/03/2018 PINNACLE WEST CAPITAL CORP PNW.N : RBC RAISES TO OUTPERFORM FROM SECTOR PERFORM; 18/04/2018 – Pinnacle West Declares Quarterly Dividend; 02/05/2018 – PINNACLE WEST CAPITAL 1Q EPS 3C, EST. 7C; 02/05/2018 – PNW 1Q OPER REV. $692.7M, EST. $681.0M (2 EST.); 29/05/2018 – PINNACLE WEST RAISES PALO VERDE 2 TO 100% FROM 0% FRIDAY: NRC; 24/05/2018 – PINNACLE WEST CUTS PALO VERDE 2 REACTOR TO 0% FROM 100%: NRC; 07/05/2018 – PINNACLE WEST RAISES PALO VERDE 3 REACTOR TO 69% FROM 0%: NRC; 03/05/2018 – S&PGR Revises Pinnacle West Capital And Sub Otlks To Stable; 14/05/2018 – Consolidated Research: 2018 Summary Expectations for Packaging Corporation of America, M&T Bank, Pinnacle West Capital, Agnico; 02/05/2018 – Pinnacle West Capital 1Q Rev $692.7M

More important recent AngioDynamics, Inc. (NASDAQ:ANGO) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: Pain Therapeutics Drops 70%, Neon To Begin Trading” on June 27, 2018, also Benzinga.com published article titled: “Benzinga’s Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street”, Benzinga.com published: “Benzinga’s Daily Biotech Pulse: Sarepta’s DMD Gene Therapy, Anika’s Flunked Trial, Eidos To Commence Trading” on June 20, 2018. More interesting news about AngioDynamics, Inc. (NASDAQ:ANGO) was released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” with publication date: June 15, 2018.

The stock decreased 0.54% or $0.12 during the last trading session, reaching $22.24. About 434,626 shares traded or 104.78% up from the average. AngioDynamics, Inc. (NASDAQ:ANGO) has risen 30.75% since July 1, 2017 and is uptrending. It has outperformed by 18.18% the S&P500. Some Historical ANGO News: 29/03/2018 – ANGIODYNAMICS INC ANGO.O SEES FY 2018 SALES $345 MLN TO $350 MLN; 26/03/2018 – AngioDynamics Presenting at Conference Tomorrow; 07/05/2018 – AngioDynamics at Deutsche Bank Health Care Conference Tomorrow; 29/03/2018 – ANGIODYNAMICS REAFFIRMS YEAR FORECAST; 29/03/2018 – AngioDynamics Backs FY18 Sales $345M-$350M; 04/04/2018 – AngioDynamics Forms Golden Cross: Technicals; 29/05/2018 – Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceutic; 29/03/2018 – ANGIODYNAMICS 3Q ADJ EPS 25C, EST. 19C; 23/04/2018 – AngioDynamics Presenting at UBS Conference May 21; 14/05/2018 – Fidelity Management & Research Exits Position in AngioDynamics

Investors sentiment increased to 1.46 in 2018 Q1. Its up 0.20, from 1.26 in 2017Q4. It improved, as 17 investors sold AngioDynamics, Inc. shares while 40 reduced holdings. 25 funds opened positions while 58 raised stakes. 34.89 million shares or 2.93% more from 33.90 million shares in 2017Q4 were reported. Rhumbline Advisers has 85,777 shares. 219,512 were reported by Millennium Management Ltd Limited Liability Company. Aqr Mngmt Ltd Com has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Manufacturers Life Insurance Communication The reported 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Ledyard Savings Bank, New Hampshire-based fund reported 1,500 shares. Fort Washington Advsrs Oh holds 0.18% or 1.03 million shares in its portfolio. 46,500 were accumulated by Strs Ohio. Amer reported 23,352 shares. Secor Advsr Limited Partnership, a New York-based fund reported 24,577 shares. Panagora Asset Mngmt holds 0.03% or 378,937 shares in its portfolio. Lapides Asset Mngmt Limited Liability Com stated it has 1.62% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Fincl Bank Of Montreal Can reported 59,400 shares or 0% of all its holdings. California Pub Employees Retirement Systems has 0% invested in AngioDynamics, Inc. (NASDAQ:ANGO) for 189,063 shares. Glenmede Tru Na owns 502 shares for 0% of their portfolio. Geode Cap Mngmt Limited Liability Company accumulated 0% or 509,354 shares.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company has market cap of $818.53 million. The firm provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It has a 617.78 P/E ratio. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

Among 7 analysts covering Pinnacle West Capital (NYSE:PNW), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Pinnacle West Capital has $88.0 highest and $78 lowest target. $84’s average target is 4.27% above currents $80.56 stock price. Pinnacle West Capital had 25 analyst reports since January 3, 2018 according to SRatingsIntel. As per Friday, May 4, the company rating was upgraded by Bank of America. The company was maintained on Thursday, March 8 by Morgan Stanley. The firm has “Hold” rating given on Friday, February 23 by SunTrust. The rating was maintained by RBC Capital Markets on Thursday, February 1 with “Hold”. The stock has “Hold” rating by SunTrust on Wednesday, April 11. The stock of Pinnacle West Capital Corporation (NYSE:PNW) earned “Hold” rating by SunTrust on Monday, April 23. SunTrust maintained it with “Hold” rating and $8400 target in Monday, April 2 report. On Monday, February 26 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The rating was maintained by Morgan Stanley on Monday, April 16 with “Equal-Weight”. The rating was maintained by SunTrust on Tuesday, January 16 with “Hold”.

Analysts await Pinnacle West Capital Corporation (NYSE:PNW) to report earnings on August, 2. They expect $1.48 EPS, down 0.67% or $0.01 from last year’s $1.49 per share. PNW’s profit will be $165.65 million for 13.61 P/E if the $1.48 EPS becomes a reality. After $0.03 actual EPS reported by Pinnacle West Capital Corporation for the previous quarter, Wall Street now forecasts 4,833.33% EPS growth.

Since January 19, 2018, it had 0 insider purchases, and 6 insider sales for $6.22 million activity. BRANDT DONALD E sold $3.02M worth of Pinnacle West Capital Corporation (NYSE:PNW) on Thursday, March 1. The insider HATFIELD JOHN S. sold $163,320. On Tuesday, May 29 the insider Schiavoni Mark A. sold $753,377. HERBERGER ROY A JR sold $162,108 worth of Pinnacle West Capital Corporation (NYSE:PNW) on Wednesday, March 14. $200,910 worth of Pinnacle West Capital Corporation (NYSE:PNW) was sold by MUNRO KATHRYN L on Wednesday, March 7.

Investors sentiment decreased to 0.94 in 2018 Q1. Its down 0.10, from 1.04 in 2017Q4. It turned negative, as 36 investors sold Pinnacle West Capital Corporation shares while 137 reduced holdings. 44 funds opened positions while 119 raised stakes. 90.61 million shares or 1.02% more from 89.70 million shares in 2017Q4 were reported. Fjarde Ap accumulated 0.03% or 20,567 shares. 100 were accumulated by Willingdon Wealth Mngmt. Raymond James & Associates has invested 0.02% of its portfolio in Pinnacle West Capital Corporation (NYSE:PNW). State Street Corp has 5.77M shares for 0.04% of their portfolio. Franklin Resource reported 1.55M shares stake. The Massachusetts-based Martingale Asset Mgmt Limited Partnership has invested 0.01% in Pinnacle West Capital Corporation (NYSE:PNW). Axa has 12,959 shares for 0% of their portfolio. Us State Bank De reported 0.01% stake. Gateway Investment Advisers Ltd Liability Co holds 0.06% or 82,462 shares. Apg Asset Mngmt Nv holds 0% of its portfolio in Pinnacle West Capital Corporation (NYSE:PNW) for 36,060 shares. Principal Group Inc has invested 0.01% of its portfolio in Pinnacle West Capital Corporation (NYSE:PNW). Daiwa Securities Gru reported 0% of its portfolio in Pinnacle West Capital Corporation (NYSE:PNW). Acadian Asset Limited Liability Com has 0.01% invested in Pinnacle West Capital Corporation (NYSE:PNW). Qs Invsts Lc has invested 0.07% in Pinnacle West Capital Corporation (NYSE:PNW). State Board Of Administration Of Florida Retirement System stated it has 160,468 shares.

Pinnacle West Capital Corporation (NYSE:PNW) Institutional Positions Chart